|
| Shirley V Wang | Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School |
| Stephen Poor | Novartis Institutes for Biomedical Research |
| Joshua J Gagne | Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School |